[HTML][HTML] Optimizing and accelerating the development of precision pain treatments for chronic pain: IMMPACT review and recommendations

RR Edwards, KL Schreiber, RH Dworkin, DC Turk… - The journal of pain, 2023 - Elsevier
Large variability in the individual response to even the most-efficacious pain treatments is
observed clinically, which has led to calls for a more personalized, tailored approach to …

[HTML][HTML] Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations

RR Edwards, RH Dworkin, DC Turk, MS Angst… - Pain …, 2021 - journals.lww.com
There is tremendous interpatient variability in the response to analgesic therapy (even for
efficacious treatments), which can be the source of great frustration in clinical practice. This …

Understanding the psychological, physiological, and genetic factors affecting precision pain medicine: a narrative review

A Chadwick, A Frazier, TW Khan… - Journal of pain …, 2021 - Taylor & Francis
Purpose Precision pain medicine focuses on employing methods to assess each patient
individually, identify their risk profile for disproportionate pain and/or the development of …

Improving neuropathic pain treatment–by rigorous stratification from bench to bedside

N Soliman, D Kersebaum, T Lawn… - Journal of …, 2023 - Wiley Online Library
Chronic pain is a constantly recurring and persistent illness, presenting a formidable
healthcare challenge for patients and physicians alike. Current first‐line analgesics offer …

Getting personal: the role of individual patient preferences and characteristics in shaping pain treatment outcomes

A Lazaridou, RR Edwards - Pain, 2016 - journals.lww.com
The topical review entitled “Must we reduce pain intensity to treat chronic pain?” by Sullivan
and Ballantyne makes a cogent and thoughtful case for the consideration of outcomes other …

Maximizing treatment efficacy through patient stratification in neuropathic pain trials

R Baron, AH Dickenson, M Calvo, SD Dib-Hajj… - Nature Reviews …, 2023 - nature.com
Abstract Treatment of neuropathic pain remains inadequate despite the elucidation of
multiple pathophysiological mechanisms and the development of promising therapeutic …

Core outcome domains for chronic pain clinical trials: IMMPACT recommendations

DC Turk, RH Dworkin, RR Allen, N Bellamy… - Pain, 2003 - Elsevier
Objective. To provide recommendations for the core outcome domains that should be
considered by investigators conducting clinical trials of the efficacy and effectiveness of …

Personalized therapy in pain management: where do we stand?

UM Stamer, L Zhang, F Stüber - Pharmacogenomics, 2010 - Taylor & Francis
Genomic variations influencing response to pharmacotherapy of pain are currently under
investigation. Drug-metabolizing enzymes represent a major target of ongoing research in …

[HTML][HTML] Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challenges

S Bruehl, AV Apkarian, JC Ballantyne, A Berger… - The Journal of …, 2013 - Elsevier
Use of opioid analgesics for pain management has increased dramatically over the past
decade, with corresponding increases in negative sequelae including overdose and death …

Interpreting patient treatment response in analgesic clinical trials: implications for genotyping, phenotyping, and personalized pain treatment

RH Dworkin, MP McDermott, JT Farrar, AB O'Connor… - PAIN®, 2014 - Elsevier
When interpreting the results of randomized clinical trials (RCTs) of efficacious pain
treatments, it is commonly concluded that some patients have responded to treatment …